Jeff Graham

Biography

Jeffrey Graham is one of Canada’s leading biotech and pharmaceutical regulatory counsel.  He is a partner in the Toronto office of Borden Ladner Gervais LLP and the leader of the firm’s national biotech and pharmaceutical group.  Jeff’s clients include domestic and international biotech and biopharmaceutical companies for whom he provides corporate and regulatory advice with respect to compliance with federal and provincial laws relating to formularies.  Jeff is a senior co-editor of the LexisNexis compilation of Federal Food and Drug Legislation and Commentary, and the lead editor of the Canadian Health Law Practice Manual, Chapter on Pharmaceuticals.  He is also the co-editor of the Thomson Reuters Commercialization of Healthcare, a global guide from Practical Law that is now in its second edition.  Jeff was the founding President of Life Sciences Ontario (formerly The Biotechnology Initiative) (LSO), the most successful community based biotechnology organization in Canada and one of the most successful organization of its kind in Canada.  He continues to serve as its corporate secretary.  He was also the Chair and President of Bioscience Education Canada (BEC) and a director of BioFinance Canada (BioFinance).  BEC founded along with Sanofi-Avantis the globally significant Biogenius Challenge Competition.  BioFinance established the first biotech finance events in Canada. He has been recognized in the Canadian Legal Lexpert Directory (Biotechnology) and by LMG Life Sciences as a leader in life sciences law. Mr. Graham received B.Comm. and B.L.C./L.L.B. degrees from McGill University and graduate degrees in international law from Cambridge University and Columbia University.

Research Interest

Pharmaceuticals,Healthcare,Biotechnology